Correlations between elevated serum levels of PRX5 and PRX6 and
clinical variables in patients
Table 2 shows possible associations between significantly elevated serum
levels of PRX5 and PRX6 and clinical parameters in patients with MS and
NMOSD. In MS patients, no significant correlation was observed between
serum PRX5 and PRX6 levels and clinical variables (CSF cell counts, CSF
protein levels, Qalb, EDSS scores, duration of disease, or oligoclonal
band positivity). Among NMOSD patients, serum PRX5 levels correlated
positively with disease duration (rs = 0.7198, p = 0.0189); and serum
PRX6 levels correlated positively with CSF protein levels (rs = 0.6727,
p = 0.0330), Qalb (rs = 0.6727, p = 0.0330), and the duration of disease
(rs = 0.6748, p = 0.0323). Significant correlations between serum PRX5
and PRX6 levels were confirmed in patients with NMOSD (rs = 0.7047,
p = 0.0229) but not MS patients (rs = 0.5924, p = 0.0711).